Moderna initiates phase 3 trial of RSV vaccine candidate

Feb. 22, 2022 8:29 AM ETModerna, Inc. (MRNA)By: Jonathan Block, SA News Editor14 Comments

Massachusetts Based Biotech Company Moderna Receives FDA Approval To Continue Coronavirus Vaccine Trials

Maddie Meyer/Getty Images News

Recommended For You

Comments (14)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.